dc.creatorRogério, Fábio
dc.creatorJordão, Hamilton
dc.creatorVieira, André Schwambach
dc.creatorMaria, Carla Cristina Judice
dc.creatorSantos de Rezende, Alexandre César
dc.creatorPereira, Gonçalo Amarante Guimarães
dc.creatorLangone, Francesco
dc.date2006-Sep
dc.date2015-11-27T13:05:39Z
dc.date2015-11-27T13:05:39Z
dc.date.accessioned2018-03-29T01:03:10Z
dc.date.available2018-03-29T01:03:10Z
dc.identifierBrain Research. v. 1112, n. 1, p. 80-90, 2006-Sep.
dc.identifier0006-8993
dc.identifier10.1016/j.brainres.2006.07.021
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/16890920
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/196863
dc.identifier16890920
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1297096
dc.descriptionPeripheral axotomy in neonatal rats induces neuronal death. We studied the anti-apoptotic protein Bcl-2 and cell death promoter Bax in spinal cord of neonatal rats after sciatic transection and treatment with melatonin, a neuroprotective substance. Pups were unilaterally axotomized at P2 and received melatonin (1 mg/kg; sc) or vehicle 1 h prior to lesion, immediately after, at 1 h, 2 h and then once daily. Rats were sacrificed at 3 h, 6 h, 24 h, 72 h and 5 days postaxotomy. Intact animals were used as controls. Lumbar enlargement was processed for Nissl staining, immunohistochemistry and RT-PCR for Bax or Bcl-2 and TUNEL reaction. Motoneurons (MN) of lesioned (L) and normal (N) sides were counted, and MN survival ratio (MSR=L/N) was calculated. Bax and Bcl-2 showed cytoplasmic immunoreactivity (IR). Bax IR was noticeable in small cells but less evident in MN. In unlesioned pups, some Bax-positive small cells (B+) and TUNEL-positive nuclei (T+) were mainly seen in the dorsal horn. In lesioned animals given vehicle, Bax mRNA levels and numbers of B+ and T+ were increased in comparison with intact controls at 24 h postaxotomy. The basal IR for Bax in MN was not changed by axotomy. Bcl-2 IR was noted in all cells and, like Bcl-2 mRNA, was unaltered after lesion. Melatonin reduced MN loss at 24 h, 72 h and 5 days and T+ at 24 h after lesion but did not interfere with Bax or Bcl-2 expression. These results suggest that (1) sciatic transection at P2 increases Bax mRNA and the amount of B+ and T+ in the lumbar enlargement, (2) Bax IR in immature MN is not altered by axotomy and (3) melatonin protects MN and dorsal horn cells through a mechanism independent of Bax and Bcl-2.
dc.description1112
dc.description80-90
dc.languageeng
dc.relationBrain Research
dc.relationBrain Res.
dc.rightsfechado
dc.rights
dc.sourcePubMed
dc.subjectAnalysis Of Variance
dc.subjectAnimals
dc.subjectAnimals, Newborn
dc.subjectAntioxidants
dc.subjectAxotomy
dc.subjectCell Count
dc.subjectDisease Models, Animal
dc.subjectGene Expression
dc.subjectGene Expression Regulation, Developmental
dc.subjectIn Situ Nick-end Labeling
dc.subjectLumbosacral Region
dc.subjectMelatonin
dc.subjectNeurons
dc.subjectProto-oncogene Proteins C-bcl-2
dc.subjectRna, Messenger
dc.subjectRats
dc.subjectReverse Transcriptase Polymerase Chain Reaction
dc.subjectSciatic Neuropathy
dc.subjectSpinal Cord
dc.subjectTime Factors
dc.subjectBcl-2-associated X Protein
dc.titleBax And Bcl-2 Expression And Tunel Labeling In Lumbar Enlargement Of Neonatal Rats After Sciatic Axotomy And Melatonin Treatment.
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución